Skip to content

SAUVENIERE: what changed

BE 0897.436.872NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€104,040
2024 · €7,430+€96,610
Equity
-€65,886
2024 · -€169,926+€104,040
Cash
€98,114
2024 · €54,065+€44,049
Balance sheet total
€351,330
2024 · €231,932+€119,397

Largest movements

2024 to 2025
Assets
  • Receivables within one year +€78,093

    up €78,093 (+220%), from €35,479 to €113,572

    of which Trade receivables: +€93,221

  • Cash +€44,049

    up €44,049 (+81.5%), from €54,065 to €98,114

    mainly Net result for the year (+€104,040) and Other debts (+€58,135)

Equity and liabilities
  • Profit (loss) carried forward +€104,040

    up €104,040 (+56.3%), from -€184,926 to -€80,886

  • Debts after one year -€72,742

    down €72,742 (-85.4%), from €85,219 to €12,477

  • Other debts +€58,135

    up €58,135, from €0 to €58,135

  • Tax, wage and social debts +€37,424

    up €37,424 (+1,977%), from €1,893 to €39,317

    of which Taxes: +€34,629

  • Current portion of long-term debt -€5,416

    down €5,416 (-3.3%), from €165,659 to €160,243

Income statement
  • Gross operating margin +€269,333

    up €269,333 (+411%), from €65,565 to €334,898

  • Financial charges +€121,835

    up €121,835 (+838%), from €14,536 to €136,371

  • Taxes +€31,761

    up €31,761 (+696%), from €4,565 to €36,326

  • Staff costs +€19,512

    up €19,512 (+60.5%), from €32,261 to €51,772

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €7,430
Gross operating margin +€269,333
Staff costs -€19,512
Depreciation -€942
Other operating charges +€1,135
Financial income +€193
Financial charges -€121,835
Taxes -€31,761
Result 2025 €104,040
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€122,207
Investment €0
Financing -€78,158
Cash 2024 €54,065
Net result for the year +€104,040
Depreciation +€1,262
Stocks and contracts +€1,484
Receivables within one year -€78,093
Trade debts -€2,044
Tax, wage and social debts +€37,424
Other debts +€58,135
Debts after one year -€72,742
Current portion of long-term debt -€5,416
Cash 2025 €98,114
brings cash intakes cash out
Every line side by side 44 lines
Line Code 2024 2025 Change %
Total assets 20/58 €231,932 €351,330 +€119,397 +51.5%
Fixed assets 21/28 €7,177 €5,916 -€1,262 -17.6%
Tangible fixed assets 22/27 €7,177 €5,916 -€1,262 -17.6%
Plant, machinery and equipment 23 €2,344 €2,055 -€289 -12.3%
Furniture and vehicles 24 €4,833 €3,860 -€973 -20.1%
Current assets 29/58 €224,755 €345,414 +€120,659 +53.7%
Stocks and contracts in progress 3 €109,964 €108,481 -€1,484 -1.3%
Stocks 30/36 €109,964 €108,481 -€1,484 -1.3%
Amounts receivable within one year 40/41 €35,479 €113,572 +€78,093 +220%
Trade receivables 40 €19,827 €113,048 +€93,221 +470%
Other amounts receivable 41 €15,651 €524 -€15,128 -96.7%
Current investments 50/53 €25,038 €25,038 = 0.0%
Cash at bank and in hand 54/58 €54,065 €98,114 +€44,049 +81.5%
Deferred charges and accrued income 490/1 €209 €209 = 0.0%
Total equity and liabilities 10/49 €231,932 €351,330 +€119,397 +51.5%
Equity 10/15 -€169,926 -€65,886 +€104,040 +61.2%
Reserves 13 €15,000 €15,000 = 0.0%
Distributable reserves 133 €15,000 €15,000 = 0.0%
Profit (loss) carried forward 14 -€184,926 -€80,886 +€104,040 +56.3%
Amounts payable 17/49 €401,859 €417,215 +€15,357 +3.8%
Amounts payable after more than one year 17 €85,219 €12,477 -€72,742 -85.4%
Financial debts 170/4 €85,219 €12,477 -€72,742 -85.4%
Amounts payable within one year 42/48 €316,419 €404,517 +€88,099 +27.8%
Current portion of amounts payable after more than one year 42 €165,659 €160,243 -€5,416 -3.3%
Trade debts 44 €148,867 €146,822 -€2,044 -1.4%
Suppliers 440/4 €148,867 €146,822 -€2,044 -1.4%
Taxes, remuneration and social security 45 €1,893 €39,317 +€37,424 +1,977%
Taxes 450/3 €1,893 €36,522 +€34,629 +1,829%
Remuneration and social security 454/9 €0 €2,795 +€2,795
Other amounts payable 47/48 €0 €58,135 +€58,135
Accrued charges and deferred income 492/3 €221 €221 = 0.0%
Remuneration, social security and pensions 62 €32,261 €51,772 +€19,512 +60.5%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €319 €1,262 +€942 +295%
Other operating charges 640/8 €6,460 €5,325 -€1,135 -17.6%
Gross operating margin 9900 €65,565 €334,898 +€269,333 +411%
Operating profit (loss) 9901 €26,526 €276,539 +€250,013 +943%
Financial income 75/76B €5 €198 +€193 +3,616%
Recurring financial income 75 €5 €198 +€193 +3,616%
Financial charges 65/66B €14,536 €136,371 +€121,835 +838%
Recurring financial charges 65 €14,536 €136,371 +€121,835 +838%
Profit (loss) for the period before taxes 9903 €11,995 €140,366 +€128,371 +1,070%
Income taxes 67/77 €4,565 €36,326 +€31,761 +696%
Profit (loss) for the period 9904 €7,430 €104,040 +€96,610 +1,300%
Profit (loss) for the period to be appropriated 9905 €7,430 €104,040 +€96,610 +1,300%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€110,532 to €167,922

Midpoint €134,445 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Worked out with Checked's starting values, not your estimate and not market data. Change the assumptions: the value follows.

Adjusted equity -€65,886
Capitalised earnings €286,950 to €401,730
Indication €110,532 to €167,922

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
-€65,886
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
-€65,886

Capitalised earnings

net result for the year (9904)
2025
€104,040
2024
€7,430
2023
€9,047
2022
€138,742
2021
-€77,808
Average result
€40,173
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€286,950 / €334,775 / €401,730

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The result is not corrected for the manager's pay. If the company pays less or more than a market salary, the capitalised earnings are too high or too low.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 19 November 2026 via checked.be.